Skip to content

Use of tooth derived (Dentin) bone graft with platelet derived growth factor for the regeneration of bone loss due to periodontitis.

Periodontal Regeneration by application of Particulate Dentin Graft (PDG) with Recombinant Human Platelet-Derived Growth Factor (RHPDGF) in human periodontal infrabony defects: An In-Vivo and In-Vitro Evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043426
Enrollment
25
Registered
2022-06-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: flap surgery (open flap debridement): Control site will be treated with open flap debridement in a single sitting procedure and follow-up for six months Control Intervention1: pdg plus

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Teeth without root canal fillings that are extracted due to advanced periodontal bone loss or fractures which have a hopeless prognosis. 2. Patient with moderate to severe chronic periodontitis with no other systemic disease. 3. Presence of deep infra-bony defect with a probing depth of >5 mm at baseline. 4. Presence of infra-bony component of at least 3 mm as detected on the radiograph. 5. Patients with a good level of oral hygiene with Plaque Index (PI, Loe and Sillness).

Exclusion criteria

Exclusion criteria: 1. Root canal treated teeth 2. Patients with systemic disease discovered on routine investigations during the study (such as diabetes mellitus, hypertension, etc.) which could influence the outcome of the study. 3. Pregnant and lactating mothers or those planning a pregnancy. 4. History within the last 6 months of oral cancer or human immunodeficiency virus (HIV). 5. Patients with life threatening disease 6. History of previous periodontal surgery on the study tooth within the last year; 7. Patients with bleeding disorders. 8. Patients suffering from allergic conditions or a history of allergies. 9. Patients on long-term antibiotics. 10. the study tooth exhibiting a Class 3 furcation defect 11. clinical or radiographic signs of untreated acute infection at the surgical site, apical pathology, root fracture, severe root irregularities, cemental pearls; cementoenamel projections not easily removed by odontoplasty, untreated carious lesions at the cementoenamel junction (CEJ) or on the root surface, subgingival restorations, and/or restorations with open margins at or below the CEJ 12. History within the last 6 months of weekly or more frequent use of smokeless chewing tobacco, pipe or cigar smoking or smoking more than 20 cigarettes per day 13. Allergy to yeast-derived products;

Design outcomes

Primary

MeasureTime frame
clinical attachment level gain Timepoint: POD at baseline and 6 months

Secondary

MeasureTime frame
Probing depth Plaque Index Gingival Index Gingival RecessionTimepoint: Baseline 6 months

Countries

India

Contacts

Public ContactDr Vishal Garg

Faculty of Dental Sciences, SGT University

amit.bhardwaj@sgtuniversity.org

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026